Meldungen sortieren nach Relevanz Meldungsdatum
|
Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis
, Forschung und Entwicklung, Nanion Technologies GmbH
Nanion Technologies is one of the leading providers of high quality automated patch clamp systems. Nanion's efficient and versatile products drastically improve...
|
Nanion Introduces the Orbit 16 – a Pioneering Device for Parallel Lipid Bilayer Recordings
, Forschung und Entwicklung, Nanion Technologies GmbH
Today, Nanion announces the introduction of a completely new product line for efficient analysis of bilayer-reconstituted ion channels and nanopores. The first of...
|
Nanion celebrates its 10th anniversary - still with a strong focus on new innovation
, Forschung und Entwicklung, Nanion Technologies GmbH
10 years ago, Nanion Technologies started out in a small loft at the Institute of Physiology of Ludwig-Maximilian’s University in Munich. Since then, Nanion has...
|
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users
, Forschung und Entwicklung, Nanion Technologies GmbH
Nanion’s ion channel screening platform, the SyncroPatch 96, has been well received within the pharmaceutical industry during the past 12 months. Experienced automated...
|
Roche's xCELLigence System Monitors Beating Periodicity of Stem Cell Derived Cardiomyocytes in Preclinical Safety Assessment
, Forschung und Entwicklung, Roche Diagnostics GmbH
Cardiac toxicity is a major concern in drug development and it is imperative that clinical candidates are thoroughly tested for adverse effects earlier in the drug...
|
Nanion’s Patchliner exceptionally well received by academic ion channel core facilities
, Forschung und Entwicklung, Nanion Technologies GmbH
The new year has started well for Nanion; in the first weeks of 2011 more than five Patchliners were sold and shipped to academic institutions intended for advanced...
|
Nanion and Axiogenesis present parallel patch clamp recordings of action potentials from Cor.At cardiomyocytes
, Forschung und Entwicklung, Nanion Technologies GmbH
Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an authentic cellular environment they are...
|
Nanion's SyncroPatch 96 validated with various targets and cells
, Forschung und Entwicklung, Nanion Technologies GmbH
The SyncroPatch 96, a high quality, high throughput patch clamp ion channel screening platform, shows impressive results with a wide variety of ion channels targets...
|
|
Nanion opens US-office in New Jersey
, Forschung und Entwicklung, Nanion Technologies GmbH
Nanion today announces the opening of Nanion Technologies Inc. with headquarters in North Brunswick, NJ, USA. To support the increasing demand of Nanion’s products,...
|
|
Nanion nominated for The German Industry's Innovation Award
, Forschung und Entwicklung, Nanion Technologies GmbH
Nanion is again nominated for a prestigious innovation award, due its impressive product portfolio of automated patch clamp systems. More than 350 companies competed...
|
|
Nanion increases throughput and cuts costs with a new industrial 96-channel patch clamp screening robot
, Medizintechnik, Nanion Technologies GmbH
Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial...
